5YL.F BRAINCOOL AB
- Market cap
- EUR 32.9M
- P/E
- -
- P/B
- 2.20x
- ROE
- -20.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 5YL.F undervalued?
Graham numberThe Graham number of BRAINCOOL AB cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BRAINCOOL AB fundamental analysis
No fundamental analysis for BRAINCOOL AB yet.
BRAINCOOL AB stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BRAINCOOL AB
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a cathet…
Full company profileBRAINCOOL AB financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BRAINCOOL AB annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 9.26M | 17.6M | 23.2M | 40.0M | 36.2M | 43.5M |
| Gross Profit | 3.97M | 13.1M | 12.1M | 12.9M | 8.62M | 12.1M |
| Operating Income | -36.4M | -38.1M | -55.1M | -42.4M | -34.4M | -34.7M |
| EBITDA | - | -32.8M | -56.5M | -39.8M | -31.6M | -28.2M |
| Net Income | -38.8M | -45.6M | -61.3M | -44.2M | -37.1M | -33.0M |
| EPS | -0.38 | -0.23 | -0.28 | -0.17 | -0.09 | -0.08 |
| Balance Sheet | ||||||
| Total Assets | 99.4M | 134M | 133M | 162M | 192M | 170M |
| Total Liabilities | 54.1M | 17.4M | 21.5M | 16.1M | 16.6M | 11.0M |
| Shareholders' Equity | 45.2M | 116M | 112M | 146M | 176M | 159M |
| Cash & Short-term Investments | 13.6M | 41.2M | 25.1M | 31.4M | 39.6M | 43.1M |
| Cash Flow | ||||||
| Operating Cash Flow | -24.2M | -46.3M | -61.2M | -62.6M | -52.7M | -47.0M |
| Capital Expenditure | 10.8M | 7.40M | 6.07M | 7.57M | 6.54M | 2.93M |
| Free Cash Flow | -35.1M | -53.7M | -67.2M | -70.2M | -59.2M | -49.9M |
| Ratios | ||||||
| ROE | -85.7% | -39.2% | -54.8% | -30.3% | -21.1% | -20.7% |
| ROA | -39.0% | -34.1% | -46.0% | -27.3% | -19.3% | -19.4% |
| Net Profit Margin | -418.3% | -259.3% | -263.8% | -110.7% | -102.3% | -75.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BRAINCOOL AB dividends
BRAINCOOL AB has not paid dividends in the last 5 fiscal years.
Who owns BRAINCOOL AB
- Insiders 32.12%
- Institutions 18.58%
- Public & others 49.30%
- Shares outstanding 395M
- Free float 357M
BRAINCOOL AB company profile
- Company name
- BRAINCOOL AB
- Ticker
- 5YL.F
- ISIN
- SE0005731833
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 15
- Fiscal year end
- December
- Address
- Medicon Village, Lund, Sweden, 223 81
- Phone
- 46 7 33 93 70 76
- Website
- braincoolinc.com
About BRAINCOOL AB
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter; Cooral system provides medical professionals a way to reduce the risk of oral mucositis; and IQool system, a temperature management system that monitors and controls a patient's temperature. In addition, the company provides products for medical cooling treatments for diseases, such as stroke, cardiac arrest, migraine, and oral mucositis. BrainCool AB (publ) was incorporated in 2010 and is based in Lund, Sweden.
BRAINCOOL AB management
4- Ms. Anna LindstromChief Executive Officer · born 1976
- Ms. Lotta ValfridssonChief Financial Officer · born 1972
- Mr. Jon BergChief Operating Officer
- Ms. Klara RasmussonCCO & Head of Clinical Affairs